208 related articles for article (PubMed ID: 26951883)
1. A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.
Sun J; Zhu M; Shen W; Wang C; Dai J; Xu L; Jin G; Hu Z; Ma H; Shen H
Pharmacogenomics J; 2017 Jun; 17(3):280-285. PubMed ID: 26951883
[TBL] [Abstract][Full Text] [Related]
2. MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese.
Dong J; Ren B; Hu Z; Chen J; Hu L; Dai J; Jin G; Xu L; Shen H
Mol Carcinog; 2011 Jun; 50(6):433-8. PubMed ID: 21268124
[TBL] [Abstract][Full Text] [Related]
3. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
[TBL] [Abstract][Full Text] [Related]
4. Analysis of MAT3 gene expression in NSCLC.
Zheng S; Du Y; Chu H; Chen X; Li P; Wang Y; Ma Y; Wang H; Zang W; Zhang G; Zhao G
Diagn Pathol; 2013 Oct; 8():166. PubMed ID: 24107548
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of ABCG2 Haplotype-tagging Single Nucleotide Polymorphisms in Patients With Unresectable Non-Small Cell Lung Cancer Treated With First-line Platinum-based Chemotherapy.
Kim SH; Kim MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY; Ling H; Lee GW
Am J Clin Oncol; 2015 Jun; 38(3):294-9. PubMed ID: 23689644
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NEAT1 polymorphisms and lung cancer susceptibility in a Chinese Northeast Han Population: A case-control study.
Wang S; Cui Z; Li H; Li J; Lv X; Yang Z; Gao M; Bi Y; Zhang Z; Zhou B; Yin Z
Pathol Res Pract; 2019 Dec; 215(12):152723. PubMed ID: 31704150
[TBL] [Abstract][Full Text] [Related]
8. The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas.
Li F; Zeng H; Ying K
Med Oncol; 2011 Dec; 28(4):1458-62. PubMed ID: 20717756
[TBL] [Abstract][Full Text] [Related]
9. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
[TBL] [Abstract][Full Text] [Related]
10. Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population.
Ma H; Chen J; Pan S; Dai J; Jin G; Hu Z; Shen H; Shu Y
Lung Cancer; 2011 Jul; 73(1):32-7. PubMed ID: 21145615
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.
Dai J; Jin G; Dong J; Chen Y; Xu L; Hu Z; Shen H
J Thorac Oncol; 2010 Nov; 5(11):1748-54. PubMed ID: 20881643
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of the stem cell marker gene
Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
BMJ Open; 2017 Aug; 7(8):e016913. PubMed ID: 28827262
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.
Bi N; Yang M; Zhang L; Chen X; Ji W; Ou G; Lin D; Wang L
Clin Cancer Res; 2010 Apr; 16(8):2383-90. PubMed ID: 20332326
[TBL] [Abstract][Full Text] [Related]
14. T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer.
Bai J; Li X; Tong D; Shi W; Song H; Li Q
Tumour Biol; 2013 Apr; 34(2):805-9. PubMed ID: 23359271
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in microRNAs predict non-small cell lung cancer prognosis in Chinese female population in a prospective cohort study.
Lingzi X; Zhihua Y; Xuelian L; Yangwu R; Haibo Z; Yuxia Z; Baosen Z
Oncotarget; 2016 Dec; 7(50):83101-83114. PubMed ID: 27825117
[TBL] [Abstract][Full Text] [Related]
16. Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.
Guan X; Yin M; Wei Q; Zhao H; Liu Z; Wang LE; Yuan X; O'Reilly MS; Komaki R; Liao Z
BMC Cancer; 2010 Aug; 10():431. PubMed ID: 20712888
[TBL] [Abstract][Full Text] [Related]
17. The association of TAP polymorphisms with non-small-cell lung cancer in the Han Chinese population.
Liu W; Ma Q; Li C; Li Y; Liu S; Shi L; Yao Y
Hum Immunol; 2021 Dec; 82(12):917-922. PubMed ID: 34373132
[TBL] [Abstract][Full Text] [Related]
18. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of the Stem Cell Marker Gene CD133 and the Risk of Lung Cancer in Chinese Population.
Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
Lung; 2016 Jun; 194(3):393-400. PubMed ID: 27130457
[TBL] [Abstract][Full Text] [Related]
20. Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.
Santarpia M; Ramirez JL; de Aguirre I; Garrido P; Pérez Cano M; Queralt C; Gonzalez-Larriba JL; Insa A; Provencio M; Isla D; Camps C; Blanco R; Moran T; Rosell R;
Clin Lung Cancer; 2017 Mar; 18(2):178-188.e4. PubMed ID: 27908619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
